Traumatic Lower Extremity Wound

Patient History

Patient is a 53-year-old male with a partial-thickness wound on their medial ankle following necrotizing fasciitis due to trauma from a motor vehicle accident. Incision and drainage (I&D) with negative pressure wound therapy (NPWT) was done multiple times to the wound prior to Restrata application. The patient is an alcoholic and suffers from coronary artery disease, acute deep vein thrombosis (DVT), and cirrhosis of the liver. *

Treatment

Restrata MiniMatrix (500mg) was applied to the wound bed, covered with a non-adherent dressing, and secured with NPWT at Week 0. NPWT was changed at Week 1. Restrata helped to fill in the defect and provided a better-granulated tissue base for STSG in this complex traumatic wound. At Week 7, the patient received STSG. The patient showed a successful graft take with excellent skin pigmentation. **

Conclusion

Once a healthy wound bed was established with Restrata, a STSG was applied Week 7. Restrata supported new granulation tissue allowing for transition to definitive closure with a STSG.

Week 0: Initial Application

Week 1: Partially Integrated

Week 2: Mostly Integrated

Week 3: Granulation Tissue Present

Week 15: 8 Weeks Post STSG

*MKG-30140

**Disclaimer: Restrata has not been studied in wounds that extend into the tendon, muscle, joint capsule, or bone. Please refer to the Instructions for Use for a full list of indications, contraindications, precautions, and warnings.

Contact an account executive today!

Get Started

or call (844) 879-2237

Revolutionizing Healing. Changing Lives.

•

Cerafix®, Covora®, and Restrata® are registered trademarks of Acera Surgical Inc.

•

Privacy & Security

This website, Acera-Surgical.com, is owned and operated by Acera Surgical. We are strongly committed to protecting the privacy of our website users. The intent of our privacy policy is to inform you, the user, about the information that we may collect about visitors to our site, how we use that information, and about our disclosure practices.

Acera Surgical is committed to high standards that require honesty, integrity and fairness. Acera Surgical will collect no personal information about you unless you choose to provide that information to us. We do not use techniques that collect personal information about you without your knowledge. You have the right to decline to have any information collected or transferred for marketing purposes.

What Happens To Your Personal Information?

All personal information that is collected on our website is stored in a secure location. At no time will Acera Surgical solicit personal information to third party vendors without prior consent, as we respect the privacy and confidentiality of our website visitors.

What About Spam?

Subscribers will not receive any unsolicited emails or correspondence if they have not provided Acera Surgical with prior permission. From time to time, we may use email as a way to keep in touch with our website visitors; however, we do not send “spam” (unsolicited marketing email). If you agree to receive email communications from us, every email message we send to you will include an email address to which you can respond. If at any time you decide you do not want to receive marketing email from us, simply let us know and we will remove your name and email address from our mailing list.

When You Leave This Site

This policy discloses the privacy practices for our website. However, our site contains links to other sites. Once you link to another site, you are subject to the privacy and security policies of the new site. We encourage you to read the privacy policies of all websites you visit, especially if you share any personal information.

Security Policy

Users are prohibited from violating or attempting to violate the security of the site. By way of example, you are prohibited from (a) accessing data not intended for such user or logging onto a server or an account which the user is not authorized to access; (b) attempting to probe, scan or test the vulnerability of a system or network or to breach security without proper authorization; (c) attempting to interfere with service to any user, host or network; (d) sending unsolicited mail, including promotions and/or advertising of products or services.